聯系我們
全國統一服務熱線:
電話:021-58446796
公司QQ:732319580
郵箱:daisy.xu@easytranslation.com.cn
網址:www.jpgfs2012.com
地址:上海浦東金橋開發區金豫路700號6號樓1樓
AstraZeneca says its coronavirus vaccine triggers immune response among adults阿斯利康表示其新冠疫苗可以觸發成人體內的免疫反應 LONDON — British pharmaceutical giant AstraZeneca on Monday said its potential Covid-19 vaccine has produced a similar immune response in older and younger adults. 倫敦-英國制藥巨頭阿斯利康在周一表示,其即將推出的Covid-19疫苗已經在老年和青壯年身體內產生類似的免疫反應。 AstraZeneca, which is developing its potential Covid-19 vaccine in collaboration with the University of Oxford, said adverse responses to the vaccine among the elderly were also found to be lower. 阿斯利康目前正在與牛津大學共同研發Covid-19疫苗。阿斯利康還發現,老年群體對疫苗所產生的副作用相對更低。 The World Health Organization has said that older people, in addition to people of all ages with preexisting medical conditions, appear to develop serious illness on contracting the coronavirus more often than others. 世界衛生組織表示,除了各個年齡段的、健康存在問題的人群之外,老年群體在感染到新冠病毒后似乎更容易出現嚴重的病癥。 The announcement is likely to boost hopes of a Covid vaccine being developed before the end of the year. 這一消息讓人們對今年年底推出新冠疫苗有了更大的希望。 “It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher,” an AstraZeneca spokesman told CNBC via email. 阿斯利康發言人通過郵件向CNBC介紹到:“看到老人和青壯年體內產生類似的免疫應答讓人倍受鼓舞,疫苗在老年體內所產生的反應原性更低,而老年群體在感染Covid-19后,其癥狀會更加嚴重。” “The results further build the body of evidence for the safety and immunogenicity of AZD1222,” the spokesman said, referring to the technical name of the Oxford-AstraZeneca vaccine. 發言人表示:“結果進一步證實了AZD1222(牛津-阿斯利康疫苗的學名)的安全性和免疫性。” Shares of the company rose more than 2% on the news. 新聞推出后,公司股價上漲超過2%。 Drugmakers and research centers are scrambling to deliver a safe and effective vaccine in an attempt to bring an end to the coronavirus pandemic that has claimed over 1.15 million lives. 制藥企業和研究機構都在爭先恐后地推出安全有效的疫苗并期望通過疫苗控制新冠疫情。目前,新冠疫情已經奪走了115萬人的生命。 Dozens of candidate vaccines are in clinical evaluation, according to the WHO, with some already conducting late-stage tests before seeking formal approval. 根據世界衛生組織介紹,目前已經有幾十個候選疫苗正處于臨床評估階段,其中一些已經在獲得正式批準前展開了大規模的測試。 The vaccine being developed by the University of Oxford and AstraZeneca is thought to be one of the frontrunners to secure regulatory approval. 由牛津大學和阿斯利康所研發的疫苗被認為是獲得監管批準的領先疫苗之一。 AstraZeneca CEO Pascal Soirot has previously said the drugmaker’s vaccine would likely provide protection against contracting the coronavirus for about a year. 阿斯利康CE0 Pascal Soirot此前表示,制藥公司推出的新冠疫苗可能會提供大約1年的免疫保護。 來源:CNBC,編輯:Susan